Yeeun Bae

The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer

Kimberly J. Cocce, Jeff S. Jasper, Taylor K. Desautels et al. · Cell Reports · 2019 · 93 citations · Full text

Medicine, Cancer Biology, Oncology +17

Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy

Suzanne E. Wardell, Alexander P. Yllanes, Christina Chao et al. · Breast Cancer Research and Treatment · 2019 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17

G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer

Kaitlyn J. Andreano, Suzanne E. Wardell, Jennifer G. Baker et al. · Breast Cancer Research and Treatment · 2020 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17